The Antibiotic Pipeline: Is there any relief in sight?

 

Join Dr. Jean Patel, principal scientist of scientific affairs at Beckman Coulter, as she presents the focus on community-associated urinary tract infections caused by ESBL-Producing Enterobacterales, and serious infections caused by carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. The list of available antibiotics today is compared with what will be available in the future. While there is some relief in sight for hard-to-treat infections, there are few drugs from new classes of antibiotics.

Presenter: Dr. Jean Patel

Dr. Jean Patel joined Beckman Coulter in 2019 after nearly 17 years at the U.S. Centers for Disease Control and Prevention (CDC) in the Antimicrobial Resistance Reference Laboratory and the Office of Antimicrobial Resistance. Prior to that, she was the Assistant Professor of Pathology and Laboratory Medicine, and the Assistant Director of Clinical Microbiology, at the University of Pennsylvania. She has held many roles with the Clinical Laboratory and Standards Institute (CLSI), including Chairholder of the Subcommittee for Antimicrobial Susceptibility Testing. She has been a member of the Trans-Atlantic Task Force on Antimicrobial Resistance and leads a World Health Organization Collaborating Center on antimicrobial resistance.